---
figid: PMC185249__1465-9921-4-5-3
figtitle: Sprouty is a rapidly inducible negative regulator of fibroblast growth factor
  (FGF) pathway signaling
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Gallus gallus
- Xenopus laevis
- Anatoecus sp. C
- Homo sapiens
organisms_ner:
- Mus musculus
- Drosophila melanogaster
- Homo sapiens
- Rattus norvegicus
- Gallus gallus
- Xenopus laevis
- Danio rerio
pmcid: PMC185249
filename: 1465-9921-4-5-3.jpg
figlink: /pmc/articles/PMC185249/figure/F3/
number: F3
caption: Sprouty is a rapidly inducible negative regulator of fibroblast growth factor
  (FGF) pathway signaling. The figure shows a model describing the interaction of
  murine Sprouty2 (mSPRY2) with other key signaling proteins in the FGF signaling
  pathway. In the upper panel, the FGF pathway is shown signaling the activation of
  MAP kinase/ERK2 via the FGFR, FRS2, Shp2, Grb2, Sos, Ras and Raf pathway. In the
  lower panel Sprouty2 (SPRY2) is shown binding FRS2 and Grb2 and displacing Shp2
  from FRS2 and Grb2, thereby preventing subsequent activation of the Sos, Ras-GAP,
  Raf pathway, resulting in net inhibition of MAP kinase/ERK2 activation.
papertitle: 'Growth factor signaling in lung morphogenetic centers: automaticity,
  stereotypy and symmetry.'
reftext: David Warburton, et al. Respir Res. 2003;4(1):5-5.
year: '2003'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9310507
figid_alias: PMC185249__F3
figtype: Figure
redirect_from: /figures/PMC185249__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC185249__1465-9921-4-5-3.html
  '@type': Dataset
  description: Sprouty is a rapidly inducible negative regulator of fibroblast growth
    factor (FGF) pathway signaling. The figure shows a model describing the interaction
    of murine Sprouty2 (mSPRY2) with other key signaling proteins in the FGF signaling
    pathway. In the upper panel, the FGF pathway is shown signaling the activation
    of MAP kinase/ERK2 via the FGFR, FRS2, Shp2, Grb2, Sos, Ras and Raf pathway. In
    the lower panel Sprouty2 (SPRY2) is shown binding FRS2 and Grb2 and displacing
    Shp2 from FRS2 and Grb2, thereby preventing subsequent activation of the Sos,
    Ras-GAP, Raf pathway, resulting in net inhibition of MAP kinase/ERK2 activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Grb2
  - Frs2
  - ras
  - Hras
  - Kras
  - Rem1
  - Ptpn11
  - Zhx2
  - Mapk3
  - Mapk1
  - Rap1gap
  - Rasa1
  - Spry2
  - btl
  - htl
  - drk
  - Ras64B
  - Ras85D
  - Sos
  - csw
  - Raf
  - rl
  - MKP-4
  - p38b
  - p38a
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - GRB2
  - FRS2
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - PTPN11
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK3
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RASA1
  - RGS6
  - SPRY2
  - grb2.L
  - grb2.S
  - frs2.L
  - ptpn11.S
  - ptpn11b.L
  - raf1.S
  - mapk1.L
  - mapk1.S
  - spry2.S
  - grb2b
  - frs2b
  - rab1ab
  - ptpn11a
  - mapk3
  - gap43
  - spry2
  - Cancer
  - Noonan syndrome
---
